Trump Slashes Medicare Drug Subsidies, Cutting Against Affordability Message
CMS says most beneficiaries will see less than a $10 monthly increase as the program ends and insurers set premiums on their own.
- On July 28, Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz announced the conclusion of the Part D Premium Stabilization Demonstration, ending a subsidy program designed to mitigate prescription drug costs for Medicare beneficiaries.
- Enacted in 2024 to stabilize premiums following the Inflation Reduction Act, the subsidy program helped insurers manage costs without passing them to enrollees; it was legislated to continue through 2027.
- Costing about $9.8 billion over two years, the demonstration offset average premiums by $16 in 2026, protecting many of the 23 million Americans enrolled in Medicare Part D from sudden cost spikes.
- Oz claimed the move prevents taxpayer money from subsidizing insurance companies, though critics argue the change will force seniors to face higher monthly costs or shift toward Medicare Advantage plans.
- Ending these protections could destabilize coverage choices as midterm elections approach, potentially pushing more beneficiaries into private Medicare Advantage plans that often impose narrower provider networks and tougher approvals.
12 Articles
12 Articles
The Federalist
Conservative ReviewWhy The Trump Administration Was Right To End The Medicare Part D Insurer Bailout
The temporary and extralegal bailout that provided billions of dollars in subsidies to insurers cost the program far more than Dems claimed.
Trump administration ends Biden-era Medicare subsidies early | Bianca Across the Nation
The Trump administration will end Biden-era Medicare Part D drug subsidies a year early, as lawmakers and administration officials weigh the impact on seniors’ prescription drug costs. NEWSMAX Chief Washington Correspondent James Rosen has more on “Bianca Across the Nation.” Watch NEWSMAX, an independent news network with a conservative perspective, available in 100M+ U.S. homes....
Trump slashes Medicare drug subsidies, cutting against affordability message
The end of a subsidy program that helped keep prices down for Medicare drug coverage could leave millions of seniors with higher monthly costs, a move that undermines the Trump administration's message of cutting drug prices. President Trump often touts his push for access to cheaper drugs through the TrumpRx platform and making “most-favored-nation” deals [...]
Coverage Details
Bias Distribution
- 50% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
